-+ 0.00%
-+ 0.00%
-+ 0.00%

ADLAI NORTYE ANNOUNCES FIRST PATIENT DOSED IN AUSTRALIA AND U.S. FDA IND CLEARANCE FOR AN4035, A FIRST-IN-CLASS PAN-RAS(ON) INHIBITOR-BASED ADC

Reuters·09/08/2026 11:00:02

Please log in to view news